Finance1 min read

We're booking big profits in 2 outperformers in Thursday's terrible market

By · Published by Everything Blog

In short

The Charitable Trust capitalized on strong corporate results by selling 50 shares of Cardinal Health and 10 shares of Eli Lilly. Both companies recently posted earnings beats and raised their full-year guidance, driving substantial share price appreciation. Even after trimming the positions, the Trust retains significant stakes to maintain portfolio diversification outside of data center investments. Cardinal Health now accounts for a 2.75% portfolio weighting, while Eli Lilly sits at 2.6%.

Key points

  • Trimming positions into significant strength allows the portfolio to harvest capital whil…: Trimming positions into significant strength allows the portfolio to harvest capital while retaining key core healthcare investments.
  • Maintaining exposure to growth healthcare companies provides vital portfolio diversificat…: Maintaining exposure to growth healthcare companies provides vital portfolio diversification away from declining data center and technology holdings.
  • All executed portfolio trades strictly complied with Club guidelines requiring mandatory…: All executed portfolio trades strictly complied with Club guidelines requiring mandatory waiting periods after alerts are issued.

Sources checked by our analysis pipeline: 1

We're locking in hefty profits in two of our growth healthcare positions Thursday. Selling 50 shares of Cardinal Health at roughly $273; Jim Cramer's Charitable Trust will own 375 shares of CAH, decreasing its weighting in the portfolio to 2.75% from 3% Selling 10 shares of Eli Lilly at roughly $1,420; the Trust will own 70 shares of LLY, decreasing its weighting in the portfolio to 2.6% from 3% Healthcare continues to outperform in a market that wants nothing to do with tech and data centers, which are getting slaughtered Thursday. CAH YTD mountain Cardinal Health YTD Cardinal Health is up more than 4%. It's one of the better performers in the S & P 500 on an otherwise ugly day for the market after the company reported a strong earnings beat and raised its full-year outlook. We'll provide more details about the quarter later in the afternoon, but this post-earnings move has extended the stock's rally to more than 20% since the end of September. Given the nice run it's had, we'll peel some stock off and raise a…

Finance